Covaxin: The asking price for transfer is 30.05 yuan per share.

Kexing Pharmaceutical Announcement: According to the inquiry and subscription situation on November 17, 2025, the preliminary determined transfer price for this inquiry is 30.05 yuan per share. The intended transferee for this inquiry has been fully subscribed, with a total of 12 institutional investors identified as the transferees, intending to transfer a total of 10.628 million shares. There are 24 institutional investors participating in this inquiry, including fund management companies, qualified overseas institutional investors, securities companies, private fund managers, and other professional institutional investors. The total number of effective subscribed shares by institutional investors participating in this inquiry is 14.877 million shares, corresponding to an effective subscription multiple of 1.48 times.